MorphoSys AG at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon, and good evening. I'm James Gordon, JPMorgan European pharma biotech analyst. And today, it gives me great pleasure to introduce Jean-Paul Kress, CEO of MorphoSys, for this Presentation at the JPMorgan Healthcare Conference.
So today, we'll have a 20-minute presentation from Jean-Paul. And then we'll have 20-minutes for questions. And then we'll also have our Chief R&D Officer, Malte Peters; and COO, Roland Wandeler. You can immediately start registering your questions. And the way to do this is with the Q&A function that's associated with this presentation on the conference website, and then I'll be reading your questions from there.
And with that said, I'd like to welcome Jean-Paul to the conference and look forward to the presentation.
Thank you, James. First, Happy New Year to all of you. I hope you're all keeping safe and healthy in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |